Pharma launch mastery: Turning unmet needs into market success

Over $200 billion in pharmaceutical revenue is at risk from loss of exclusivity by 2030, and more than 80% of launches set their long-term trajectory within the first six months - making early performance critical.

In this episode of Shaping Healthcare, Yuliana, Senior Director at Citius Healthcare Consulting, shares proven strategies for achieving launch excellence in a fast-paced, competitive market. Drawing on experience across global launches, she emphasizes fundamentals that remain constant despite evolving trends like AI and post-COVID dynamics.

Key takeaways:

• Early performance in the first six months defines the long-term success of a pharma launch
• Mastering the fundamentals, the four Ps, remains essential even amid evolving trends like AI
• Investing in people and patient access creates a sustainable competitive advantage
• Balancing innovation with proven strategies ensures consistent results

Tune in to learn why fundamentals, patient access, and people matter most - while balancing innovation with proven strategies.

Read more about Citius Healthcare Consulting - Life Sciences initiatives.